Showing results (71-80 of 99) with videos related to

Sort By:
Pageof 10
Herz|October 4, 2014
ECG-gated coronary angiography enables submillisievert imaging in invasive cardiologyE Kuon, S B Felix, K Weitmann, et al.
American Heart Journal|June 30, 2000
A1166C polymorphism of the angiotensin II type 1 receptor gene and risk of adverse events after coronary catheter interventionsK Stangl, I Cascorbi, V Stangl, et al.
Herz|December 10, 2013
Latest-generation catheterization systems enable invasive submillisievert coronary angiographyE Kuon, K Weitmann, A Hummel, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|April 25, 2002
Cessation of pulmonary and coronary secretion of adrenomedullin peptides in the progression of human heart failureK Stangl, T Dschietzig, C Richter, et al.
Research in Experimental Medicine. Zeitschrift Fur Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie|January 1, 1981
Cardiac contractile and metabolic effects mediated via the myocardial H2-receptor adenylate cyclase system. Characterization of two new specific H2-receptor agonists, impromidine and dimaprit, in the guinea pig and human myocardiumG Baumann, S B Felix, J Schrader, et al.
Lancet (London, England)|March 12, 1999
A1/A2 polymorphism of glycoprotein IIIa and association with excess procedural risk for coronary catheter interventions: a case-controlled studyM Laule, I Cascorbi, V Stangl, et al.
Journal of the American College of Cardiology|October 5, 2001
Role of Kozak sequence polymorphism of platelet glycoprotein Ibalpha as a risk factor for coronary artery disease and catheter interventionsC Meisel, V Afshar-Kharghan, I Cascorbi, et al.
Circulation|June 8, 2001
Immunohistological changes in dilated cardiomyopathy induced by immunoadsorption therapy and subsequent immunoglobulin substitutionA Staudt, F Schäper, V Stangl, et al.
Pharmacogenetics|April 13, 2000
High CA repeat numbers in intron 13 of the endothelial nitric oxide synthase gene and increased risk of coronary artery diseaseK Stangl, I Cascorbi, M Laule, et al.
Cancer Research|January 1, 1991
Some antagonists of platelet activating factor are cytotoxic for human malignant cell linesS Danhauser-Riedl, S B Felix, W J Houlihan, et al.
Pageof 10